ER - Cell Line Control, Dynamic Range

Products
- Dynamic Range Controls
  - HER2^DR
  - ER^DR
  - PR^DR
  - BREAST^DR
  - HPV/p16^DR
  - PD-L1^DR
  - ROS1^DR
  - ALK^DR
- Standard Controls
  - MMR
  - MLH1/PMS2
  - MSH2
  - MSH6
  - ALK-EML4
  - ROS1
  - ALK-NPM
  - ER, PGR, HER2
  - HPV/p16
  - NTRK
- Antibodies
  - hTERT
Services
About
Latest
Contact
- Contact Us
- Distributors

ER Dynamic Range Analyte Control

Our ER Dynamic Range Analyte Control contains four cores, offering a full range of expression for ER: Negative, Low, Medium, High. Available now, please contact sales@histocyte.com or visit one of our distributors.

[HCL029]: ER Analyte Control^DR (2 unstained slides)

Datasheet / SDS / Brochure / Enquire

[HCL030]: ER Analyte Control^DR (5 unstained slides)

Datasheet / SDS / Brochure / Enquire

[HCL031]: ER Analyte Control^DR (1 cell microarray block)

Datasheet / SDS / Brochure / Enquire

ER IHC

Introduction

Estrogen receptor has long been a target for treatment in breast cancer, with the greatest impact occurring with the introduction of Tamoxifen. Tamoxifen is a selective ER modulator (SERM) as it binds to ER causing dimerization yet does not induce the same recruitment of co-activators as the estrogens do. Newer therapies such as the aromatase inhibitors (AI) have demonstrated a greater effectiveness in both the adjuvant and metastatic setting.